Spacer inhalation technique and deposition of extrafine aerosol asthmatic children

European Respiratory Journal

Volumn 29, Issue 2, 2007, Pages 299-306

  Roller, C M ^a   Zhang, G ^a   Troedson, R G ^a   Leach, C L ^b   Le Souef P N ^a   Devadason, S G ^a  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Children; Deposition study; Inhalation technique; Spacers

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUORINATED HYDROCARBON; SALBUTAMOL;

ADOLESCENT; AEROSOL; ARTICLE; ASTHMA; BREATH HOLDING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FORCED EXPIRATORY VOLUME; GAMMA SCINTIGRAPHY; GASTROINTESTINAL TRACT; HUMAN; ISOTOPE LABELING; LUNG; LUNG FUNCTION TEST; MALE; METERED DOSE INHALER; OROPHARYNX; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADOLESCENT; AEROSOLS; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LUNG; MALE; METERED DOSE INHALERS; OROPHARYNX; TISSUE DISTRIBUTION;

EID: 33846934467     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00051106     Document Type: Article

References (38)

1. Tulic MK, Christodoulopoulos P, Hamid Q. Small airway inflammation in asthma. Respir Res 2001; 2: 333-339.
2. Dubus JC, de Blic J, Mezzi K. The role of the small airways in childhood asthma. Rev Mal Respir 2004; 21: 737-742.
3. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505-1510.
4. Van Asperen PP, Mellis CM, Sly PD. The role of corticosteroids in the management of childhood asthma. The Thoracic Society of Australia and New Zealand. Med J Aust 1992; 156: 48-52.
5. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature. J Allergy Clin Immunol 1997; 100: 452-457.
6. Lawrence M, Wolfe J, Webb DR, et al. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity. Am J Respir Crit Care Med 1997; 156: 744-751.
7. Colice GL. Pharmacodynamic and pharmacokinetic considerations in choosing an inhaled corticosteroid. Treat Respir Med 2006; 5: 245-253.
8. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003; 56: 600-612.
9. Devadason SG, Le Souëf PN. Age-associated factors influencing the efficacy of various forms of aerosol therapy. J Aerosol Med 2002; 15: 343-345.
10. Leach C. Targeting inhaled steroids. Int J Clin Pract Suppl 1998; 96: 23-27.
11. Skoner DP. Balancing safety and efficacy in pediatric asthma management. Pediatrics 2002; 109: Suppl. 2, 381-392.
12. Juniper EF, Price DB, Stampone PA, Creeners JP, Mol SJ, Fireman P. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002; 121: 1824-1832.
13. Ederle K. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study. Eur Rev Med Pharmacol Sci 2003; 7: 45-55.
14. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998; 12: 1346-1353.
15. Davies RJ, Stampone P, O'Connor BJ. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir Med 1998; 92: Suppl. A, 23-31.
16. Agertoft L, Laulund LW, Harrison LI, Pedersen S. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children. Pediatr Pulmonol 2003; 35: 192-199.
17. Devadason SG, Huang T, Walker S, Troedson R, Le Souëf PN. Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children. Eur Respir J 2003; 21: 1007-1011.
18. Szefler SJ, Warner J, Staab D, et al. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open-label, randomized trial. J Allergy Clin Immunol 2002; 110: 45-50.
19. Wildhaber JH, Janssens HM, Pierart F, Dore ND, Devadason SG, Le Souëf PN. High-percentage lung delivery in children from detergent-treated spacers. Pediatr Pulmonol 2000; 29: 389-393.
20. Barry PW, O'Callaghan C. A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices. Br J Clin Pharmacol 1999; 47: 357-360.
21. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report: Guidelines and Resources. National Institutes of Health Publication No. 95-3659. Bethesda, National Heart, Lung and Blood Institute, 1995.
22. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976; 113: 587-600.
23. Macey DJ, Marshall R. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J Nucl Med 1982; 23: 731-734.
24. Australian Radiation Protection and Nuclear Safety Agency (ARPANSA). Code of Practice for the Exposure of Humans to Ionizing Radiation for Research Purposes (2005). Radiation Protection Series Publication No. 8. Melbourne, ARPANSA, 2005.
25. Kamiya A, Sakagami M, Hindle M, Byron PR. Aerodynamic sizing of metered dose inhalers: An evaluation of the andersen and next generation pharmaceutical impactors and their USP method. J Pharm Sci 2004; 93: 1828-1837.
26. Dubus JC, Mely L, Huiart L, Marquet C, Le Roux P. Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma. Fundam Clin Pharmacol 2003; 17: 627-631.
27. Leach C. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol 1999; 104: S250-S252.
28. Wildhaber JH, Devadason SG, Wilson JM, et al. Lung deposition of budesonide from turbuhaler in asthmatic children. Eur J Pediatr 1998; 157: 1017-1022.
29. Kamps AW, van Ewijk B, Roorda R J, Brand PL. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 2000; 29: 39-42.
30. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127: 335-371.
31. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler. J Aerosol Med 2005; 18: 379-385.
32. Wildhaber JH, Monkhoff M, Sennhauser FH. Dosage regimens for inhaled therapy in children should be reconsidered. J Paediatr Child Health 2002; 38: 115-116.
33. Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf 2000; 23: 11-33.
34. Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000; 106: 1209-1226.
35. Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996; 154: 771-782.
36. de Jong PA, Muller NL, Pare PD, Coxson HO. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J 2005; 26: 140-152.
37. Goldin JG, Tashkin DP, Kleerup EC, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical, thin-section computed tomography. J Allergy Clin Immunol 1999; 104: S258-S267.
38. Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ. Airway and systemic effects of hydrofluoro-alkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Chest 2005; 127: 851-860.